Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
The official podcast of the Australasian Society for Intellectual Disability (ASID). We bring you the latest in Australian and New Zealand research into improving the rights and quality of life for people with intellectual disability. Find out more about ASID at our website http://asid.asn.au/ or follow us on social media: Twitter @ASID_Ltd Facebook: @asid.asn.au .
…
continue reading
1
Urothelial Bladder Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
1:02:32
1:02:32
Na później
Na później
Listy
Polub
Polubione
1:02:32
Featuring perspectives from Dr Matthew D Galsky and Dr Ashish M Kamat, including the following topics: Introduction: Urologist for Life (0:00) Non-Muscle-Invasive Urothelial Bladder Cancer (UBC) Update (9:54) Enfortumab Vedotin/Pembrolizumab Now and in the Future (30:21) HER2-Positive UBC (37:33) Future Directions — ctDNA (55:39) CME information an…
…
continue reading
1
Myelofibrosis | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Myelofibrosis
1:30:32
1:30:32
Na później
Na później
Listy
Polub
Polubione
1:30:32
Featuring perspectives from Ms Ilene Galinsky, Dr Andrew T Kuykendall, Dr Sara M Tinsley-Vance and Dr Abdulraheem Yacoub, including the following topics: Introduction (0:00) The Biology of Myelofibrosis (MF) (14:00) Role of Available and Investigational JAK inhibitors for the Management of MF (45:49) Promising Agents and Strategies for Patients wit…
…
continue reading
1
Ovarian Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Ovarian Cancer
1:32:21
1:32:21
Na później
Na później
Listy
Polub
Polubione
1:32:21
Featuring perspectives from Ms Courtney Arn, Dr Floor J Backes, Dr Kathleen N Moore and Ms Jaclyn Shaver, including the following topics: Introduction: The Incidence, Pathogenesis and Prognosis of Ovarian Cancer (0:00) Genetic Testing for Newly Diagnosed Advanced Ovarian Cancer (11:01) The Role of PARP Inhibitor Maintenance for Newly Diagnosed Adva…
…
continue reading
1
Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer
1:31:08
1:31:08
Na później
Na później
Listy
Polub
Polubione
1:31:08
Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics: Introduction (0:00) The Biology of Head and Neck Cancer (15:41) The Multidisciplinary Treatment of Head and Neck Cancer (18:14) Ongoing Screening and Prevention After Potentially Curative Therapy for Head and …
…
continue reading
1
Prostate Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Prostate Cancer
1:59:31
1:59:31
Na później
Na później
Listy
Polub
Polubione
1:59:31
Featuring perspectives from Dr Rahul Aggarwal, Dr Adam S Kibel, Dr Laurence Klotz and Dr Sandy Srinivas, moderated by Dr Elisabeth I Heath, including the following topics: Introduction (0:00) Recent Data Defining the Optimal Use of Hormonal Therapy for Nonmetastatic Prostate Cancer — Dr Kibel (2:39) Side Effects and Other Practical Considerations w…
…
continue reading
1
Lymphoma | Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
1:16:46
1:16:46
Na później
Na później
Listy
Polub
Polubione
1:16:46
Featuring perspectives from Dr Andrew D Zelenetz, including the following topics: Follicular Lymphoma (0:00) Mantle Cell Lymphoma (30:29) Diffuse Large B-Cell Lymphoma (55:01) Hodgkin Lymphoma (1:12:25) CME information and select publicationsAutor: Dr. Neil Love
…
continue reading
1
Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Companion Faculty Lecture)
35:54
35:54
Na później
Na później
Listy
Polub
Polubione
35:54
Featuring a slide presentation and related discussion from Dr Elias Jabbour, including the following topics: Clinical management of Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL); factors in the selection of initial induction treatment (0:00) Primary and secondary endpoint outcomes from the Phase III PhALLCON tri…
…
continue reading
1
Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
33:40
33:40
Na później
Na później
Listy
Polub
Polubione
33:40
Featuring an interview with Dr Elias Jabbour, including the following topics: Evolution of research and therapeutic options for acute lymphoblastic leukemia (ALL) (0:00) Clinical and biological characteristics of ALL and implications for prognosis and disease management (6:36) Case: A 48-year-old woman with newly diagnosed Philadelphia chromosome-p…
…
continue reading
1
Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)
29:05
29:05
Na później
Na później
Listy
Polub
Polubione
29:05
Featuring a slide presentation and related discussion from Dr Joshua Richter, including the following topics: Similarities and differences between the cellular targets and mechanisms of action of BCMA- and non-BCMA-directed bispecific antibodies for multiple myeloma (MM) (0:00) Antitumor activity observed with teclistamab and elranatamab for relaps…
…
continue reading
1
Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
41:54
41:54
Na później
Na później
Listy
Polub
Polubione
41:54
Featuring an interview with Dr Joshua Richter, including the following topics: Management of cytokine release syndrome after bispecific antibody therapy; importance of clinical trials in the multiple myeloma (MM) treatment paradigm (0:00) Similarities and differences between and efficacy and tolerability of BCMA- and non-BCMA-directed bispecific an…
…
continue reading
1
Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers
1:29:58
1:29:58
Na później
Na później
Listy
Polub
Polubione
1:29:58
Featuring perspectives from Ms Blanca Ledezma, Dr Stacey Stein, Ms Amanda K Wagner and Dr Mark Yarchoan, including the following topics: Introduction (0:00) Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma (HCC) (9:40) Role of Immunotherapy in Intermediate-Stage HCC (17:02) First-Line Therapy for Advanced HCC (19:56) Immunotherapy in the M…
…
continue reading
1
HER2-Positive Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
1:16:17
1:16:17
Na później
Na później
Listy
Polub
Polubione
1:16:17
Featuring perspectives from Dr Adam M Brufsky, including the following topics: Review of Local Therapy (0:00) Treatment Advances for HER2 Positive Early-Stage Breast Cancer (18:35) Case: A woman in her early 60s with ER-positive, HER2-positive (IHC 3+) with infiltrating ductal carcinoma who received T-DM1 with an aromatase inhibitor (19:37) Case: A…
…
continue reading
1
Endometrial Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Endometrial Cancer
1:30:22
1:30:22
Na później
Na później
Listy
Polub
Polubione
1:30:22
Featuring perspectives from Ms Jennifer Filipi, Ms Kathryn Lyle, Dr David O’Malley and Dr Shannon N Westin, including the following topics: Introduction (0:00) Incidence and Biology of Endometrial Cancer (EC) (9:30) Use of Immune Checkpoint Inhibitors as Monotherapy for EC (23:24) First-Line Therapy for Primary Advanced or Recurrent EC (28:28) Lenv…
…
continue reading